Cytocompatibility and Bioactive Properties of Hydraulic Calcium Silicate-Based Cements (HCSCs) on Stem Cells from Human Exfoliated Deciduous Teeth (SHEDs): A Systematic Review of In Vitro Studies.
bioactivity
bioceramic
calcium silicate cements
cell viability
dental stem cells
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Nov 2020
28 Nov 2020
Historique:
received:
03
11
2020
revised:
20
11
2020
accepted:
25
11
2020
entrez:
2
12
2020
pubmed:
3
12
2020
medline:
3
12
2020
Statut:
epublish
Résumé
The implementation of hydraulic calcium silicate-based endodontic cements (HCSCs) in biologically based endodontic procedures for the primary dentition has been recently investigated, focusing on the biological response of stem cells from human exfoliated deciduous teeth (SHEDs) towards them. The present systematic review aimed to present a qualitative synthesis of the available literature consisting of in vitro assays, which assessed the cytocompatibility and bioactive properties of HCSCs in direct contact with SHEDs. Following the PRISMA statement, an electronic database search was carried out in Medline, Scopus, Embase, Web of Science, and SciELO on March 31st and updated on November 16th, 2020. In vitro studies evaluating the biological response of SHEDs to the treatment with HCSCs were eligible. Within the term biological response, assays assessing the cytocompatibility (i.e., cell viability, migration, proliferation), cell plasticity or differentiation (i.e., osteo/odontogenic marker expression), and bioactivity or biomineralization (i.e., mineralized nodule formation) were included. A total of seven studies were included after the selection process. The study sample comprised an extensive range of cell viability, migration, proliferation, adhesion, and bioactivity assays regarding the biological response of SHEDs towards five different commercially available HCSCs (MTA, ProRoot MTA, Biodentine, iRoot BP Plus, and Theracal LC). Biodentine, MTA, and iRoot BP Plus showed significant positive results in cytocompatibility and bioactivity assays when cultured with SHEDs. The results from in vitro assays assessing the cytocompatibility and bioactivity of the HCSCs MTA, Biodentine, and iRoot BP Plus towards SHEDs support their use in vital pulp treatment for the primary dentition.
Identifiants
pubmed: 33260782
pii: jcm9123872
doi: 10.3390/jcm9123872
pmc: PMC7761433
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Int Endod J. 2019 Mar;52(3):261-266
pubmed: 30724394
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
BMC Pharmacol Toxicol. 2018 May 15;19(1):21
pubmed: 29764492
Materials (Basel). 2020 Jun 12;13(12):
pubmed: 32545425
J Endod. 2010 Feb;36(2):190-202
pubmed: 20113774
Int Endod J. 2018 Aug;51(8):829-846
pubmed: 29405371
J Dent. 2015 Feb;43(2):241-7
pubmed: 25478890
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Int Endod J. 2011 Sep;44(9):800-6
pubmed: 21477154
Dent Mater. 2018 May;34(5):797-808
pubmed: 29525357
Biomed Res Int. 2017;2017:4059703
pubmed: 29226134
Materials (Basel). 2020 Feb 21;13(4):
pubmed: 32098171
Arch Oral Biol. 2012 Sep;57(9):1231-40
pubmed: 22455989
Cell Tissue Res. 2010 May;340(2):323-33
pubmed: 20309582
Int Endod J. 2019 Jul;52(7):949-973
pubmed: 30985944
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
J Endod. 2013 Apr;39(4):478-83
pubmed: 23522540
J Clin Med. 2020 Mar 19;9(3):
pubmed: 32204501
Eur J Paediatr Dent. 2018 Dec;19(4):257
pubmed: 30567439
Clin Oral Investig. 2019 Feb;23(2):661-666
pubmed: 29744721
J Evid Based Dent Pract. 2019 Mar;19(1):17-27
pubmed: 30926099
Pediatr Dent. 2017 Jan 15;39(1):16-123
pubmed: 28292337
Dent Mater. 2018 Dec;34(12):1797-1813
pubmed: 30316525
J Endod. 2018 Jan;44(1):126-132
pubmed: 29079052
Stem Cells Dev. 2019 Aug 1;28(15):1050-1058
pubmed: 31169063
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5807-12
pubmed: 12716973
J Endod. 2011 Dec;37(12):1647-52
pubmed: 22099898
J Appl Oral Sci. 2011 May-Jun;19(3):189-94
pubmed: 21625731
Saudi Dent J. 2020 Jan;32(1):43-51
pubmed: 31920278
Development. 2016 Jul 1;143(13):2273-80
pubmed: 27381225
J Evid Based Dent Pract. 2012 Dec;12(4):182-9
pubmed: 23177493
Dent Mater. 2014 Jan;30(1):50-61
pubmed: 24113131
J Dent. 2019 May;84:1-8
pubmed: 30981748
Int Endod J. 2017 Dec;50 Suppl 2:e63-e72
pubmed: 28891221
Dent Traumatol. 2014 Apr;30(2):100-6
pubmed: 24138100
Mol Biol Rep. 2012 Jan;39(1):215-20
pubmed: 21559841
J Endod. 2017 Nov;43(11):1786-1791
pubmed: 28822566
J Dent Res. 2009 Sep;88(9):792-806
pubmed: 19767575
Int Endod J. 2017 Mar;50(3):281-292
pubmed: 26913698
Int Endod J. 2017 Aug;50(8):780-789
pubmed: 27520288
Indian J Dent Res. 2018 Nov-Dec;29(6):787-793
pubmed: 30589009
PLoS One. 2018 Jan 25;13(1):e0190014
pubmed: 29370163
Clin Cosmet Investig Dent. 2019 Jul 12;11:181-193
pubmed: 31372059
J Endod. 2015 Nov;41(11):1805-17
pubmed: 26381895
Dent Mater. 2015 Apr;31(4):351-70
pubmed: 25662204
J Dent. 2014 Apr;42(4):490-7
pubmed: 24440605
J Endod. 2013 Jun;39(6):801-5
pubmed: 23683282
J Dent Res. 2010 Aug;89(8):791-6
pubmed: 20395410
Shanghai Kou Qiang Yi Xue. 2019 Jun;28(3):251-258
pubmed: 31489411
J Conserv Dent. 2018 Sep-Oct;21(5):466-473
pubmed: 30294104
Materials (Basel). 2019 Mar 27;12(7):
pubmed: 30934746
Open Access Maced J Med Sci. 2018 Sep 23;6(9):1727-1731
pubmed: 30337999
Stem Cells Int. 2017;2017:2416254
pubmed: 28761445
Braz Dent J. 2015 Nov-Dec;26(6):587-91
pubmed: 26963200
Clin Oral Investig. 2019 Apr;23(4):1967-1976
pubmed: 30238414
Materials (Basel). 2020 May 10;13(9):
pubmed: 32397585
Clin Oral Investig. 2016 Sep;20(7):1639-45
pubmed: 26578117
Eur Arch Paediatr Dent. 2018 Jun;19(3):197-203
pubmed: 29767382
Int Endod J. 2017 Dec;50 Suppl 2:e19-e30
pubmed: 28169432
Dent Mater. 2018 May;34(5):693-694
pubmed: 29571660
J Appl Oral Sci. 2018 Feb 01;26:e20160629
pubmed: 29412365
Int Endod J. 2019 Jul;52(7):923-934
pubmed: 30664240